Tengjun Biotechnology Corp Performance
| TJBHDelisted Stock | USD 2.00 0.00 0.00% |
The entity has a beta of 0.0, which indicates not very significant fluctuations relative to the market. the returns on MARKET and Tengjun Biotechnology are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Tengjun Biotechnology Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong fundamental drivers, Tengjun Biotechnology is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders. ...more
| Begin Period Cash Flow | 6238.00 | |
| Total Cashflows From Investing Activities | -20.6 K | |
| Free Cash Flow | -871.5 K |
Tengjun |
Tengjun Biotechnology Relative Risk vs. Return Landscape
If you would invest 200.00 in Tengjun Biotechnology Corp on October 1, 2025 and sell it today you would earn a total of 0.00 from holding Tengjun Biotechnology Corp or generate 0.0% return on investment over 90 days. Tengjun Biotechnology Corp is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of otc stocks are less volatile than Tengjun, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Tengjun Biotechnology Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Tengjun Biotechnology's investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Tengjun Biotechnology Corp, and traders can use it to determine the average amount a Tengjun Biotechnology's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| TJBH |
Based on monthly moving average Tengjun Biotechnology is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Tengjun Biotechnology by adding Tengjun Biotechnology to a well-diversified portfolio.
Tengjun Biotechnology Fundamentals Growth
Tengjun OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Tengjun Biotechnology, and Tengjun Biotechnology fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Tengjun OTC Stock performance.
| Return On Equity | 2.01 | |||
| Return On Asset | 0.34 | |||
| Profit Margin | 0.08 % | |||
| Operating Margin | 0.10 % | |||
| Current Valuation | 385.53 M | |||
| Shares Outstanding | 96.31 M | |||
| Price To Book | 50.08 X | |||
| Price To Sales | 4.19 X | |||
| EBITDA | (424.11 K) | |||
| Cash And Equivalents | 6.76 M | |||
| Cash Per Share | 0.08 X | |||
| Total Debt | 301.43 K | |||
| Book Value Per Share | 0.09 X | |||
| Cash Flow From Operations | (561.3 K) | |||
| Earnings Per Share | 0.09 X | |||
| Total Asset | 14.03 M | |||
About Tengjun Biotechnology Performance
By evaluating Tengjun Biotechnology's fundamental ratios, stakeholders can gain valuable insights into Tengjun Biotechnology's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Tengjun Biotechnology has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Tengjun Biotechnology has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Tengjun Biotechnology Corp., through its subsidiaries, engages in producing, distributing, and marketing featured dandelion teas and water purifiers in the Peoples Republic of China. It offers black and green dandelion teas and household water purifiers. Tengjun Biotechnology is traded on OTC Exchange in the United States.Things to note about Tengjun Biotechnology performance evaluation
Checking the ongoing alerts about Tengjun Biotechnology for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Tengjun Biotechnology help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Tengjun Biotechnology is not yet fully synchronised with the market data | |
| Tengjun Biotechnology has a very high chance of going through financial distress in the upcoming years | |
| Tengjun Biotechnology Corp currently holds 301.43 K in liabilities. Tengjun Biotechnology has a current ratio of 0.69, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Tengjun Biotechnology until it has trouble settling it off, either with new capital or with free cash flow. So, Tengjun Biotechnology's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Tengjun Biotechnology sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Tengjun to invest in growth at high rates of return. When we think about Tengjun Biotechnology's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (747.52 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Tengjun Biotechnology Corp currently holds about 6.76 M in cash with (561.3 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.08. | |
| Roughly 53.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Tengjun Biotechnology's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Tengjun Biotechnology's stock is overvalued or undervalued compared to its peers.
- Examining Tengjun Biotechnology's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Tengjun Biotechnology's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Tengjun Biotechnology's management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Tengjun Biotechnology's otc stock. These opinions can provide insight into Tengjun Biotechnology's potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the Tengjun Biotechnology information on this page should be used as a complementary analysis to other Tengjun Biotechnology's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Consideration for investing in Tengjun OTC Stock
If you are still planning to invest in Tengjun Biotechnology check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tengjun Biotechnology's history and understand the potential risks before investing.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |